Medifast earnings were $2.1M for the trailing 12 months ending Dec 31, 2024, with -97.9% growth year over year. The latest MED earnings report on Dec 31, 2024 announced Q4 2024 earnings of $801.0k, down 29.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MED reported annual earnings of $2.1M, with -97.9% growth.
MED past earnings growth
How has MED's earnings growth performed historically?
On MED's earnings call on Invalid Date, Medifast (NYSE: MED) reported Q4 2024 earnings per share (EPS) of $0.07, up 87.27% year over year. Total MED earnings for the quarter were $801.00 thousand. In the same quarter last year, Medifast's earnings per share (EPS) was $0.55.
As of the last Medifast earnings report, Medifast is currently profitable. Medifast's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $2.09 million, a 97.9% decrease year over year.
What was MED's earnings growth in the past year?
As of Medifast's earnings date in Invalid Date, Medifast's earnings has grown -97.92% year over year. This is 113.69 percentage points lower than the US Personal Services industry earnings growth rate of 15.77%. MED earnings in the past year totalled $2.09 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.